We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Fragments Protect Against Botulinum Toxin

By Biotechdaily staff writers
Posted on 14 Oct 2003
Researchers have identified the molecules that bind and transport botulinum toxin (BoNT), a bacterial toxin that causes paralysis and is extremely toxic even at very low concentrations.

Previous research had shown that complex cell membrane glycolipids known as gangliosides were involved along with some proteins in the internalization of botulinum toxin. More...
Investigators at the University of Wisconsin (Madison, USA; www.wisc.edu) employed both tissue culture and animal experiments to identify the protein component.

The investigators reported in a study published in the September 29, 2003, issue of the Journal of Cell Biology that they used gain-of-function and loss-of-function approaches to show that the secretory vesicle proteins, synaptotagmins (syts) I and II, mediated the entry of BoNT/B (but not BoNT/A or E) into PC12 tissue culture cells. They also demonstrated that BoNT/B entry into PC12 cells and rat diaphragm motor nerve terminals was activity dependent and could be blocked using fragments of syt II that contain the BoNT/B-binding domain. Finally, they showed that syt II fragments, in conjunction with gangliosides, neutralized BoNT/B in intact mice.

Senior author Dr. Edwin Chapman, professor of physiology at the University of Wisconsin explained, "The fragments are a protective agent, a scavenger, that prevents the toxin from reaching its target.”



Related Links:
University of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.